{"entity":{"type":"insider","cik":"0001334365","url":"/insider/0001334365","json_url":"/insider/0001334365.json","name":"Lee Yuchun","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":591,"n_filings":61,"first":"2006-09-08","last":"2023-01-31","span_basis":"filed_date"},"name_variants":[{"name":"Lee Yuchun","source":"filing","n_filings":61,"first_seen":"2006-09-08","last_seen":"2023-01-31"}],"transactions":[{"id":8701204,"accession":"0001209191-23-005712","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-005712","line_url":"/filing/0001209191-23-005712","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1429.0,"shares_display":"1,429","price_per_share":322.02721483554933,"price_display":"322.03","price_state":"stated","total_value":460176.89,"total_display":"460,176.89","total_whole":"460,177","shares_owned_after":1955.0,"shares_owned_after_display":"1,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-31","scope":"insider","n_lines":3},{"id":8677363,"accession":"0001209191-23-005234","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-23-005234","line_url":"/filing/0001209191-23-005234","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":318.330585,"price_display":"318.33","price_state":"stated","total_value":1273322.34,"total_display":"1,273,322.34","total_whole":"1,273,322","shares_owned_after":4433.0,"shares_owned_after_display":"4,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-26","filed_date":"2023-01-27","scope":"insider","n_lines":6},{"id":8677351,"accession":"0001209191-23-005234","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-005234","line_url":"/filing/0001209191-23-005234","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":313.9630375,"price_display":"313.96","price_state":"stated","total_value":1255852.15,"total_display":"1,255,852.15","total_whole":"1,255,852","shares_owned_after":2454.0,"shares_owned_after_display":"2,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-27","scope":"insider","n_lines":3},{"id":8743138,"accession":"0001209191-23-004816","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-004816","line_url":"/filing/0001209191-23-004816","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":312.6883075,"price_display":"312.69","price_state":"stated","total_value":1250753.23,"total_display":"1,250,753.23","total_whole":"1,250,753","shares_owned_after":3364.0,"shares_owned_after_display":"3,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-25","scope":"insider","n_lines":2},{"id":8743129,"accession":"0001209191-23-004816","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-004816","line_url":"/filing/0001209191-23-004816#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2129.0,"shares_display":"2,129","price_per_share":312.02,"price_display":"312.02","price_state":"stated","total_value":664290.58,"total_display":"664,290.58","total_whole":"664,291","shares_owned_after":1875.0,"shares_owned_after_display":"1,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":8287332,"accession":"0001209191-23-004005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-004005","line_url":"/filing/0001209191-23-004005#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":442.0,"shares_display":"442","price_per_share":312.17,"price_display":"312.17","price_state":"stated","total_value":137979.14,"total_display":"137,979.14","total_whole":"137,979","shares_owned_after":1875.0,"shares_owned_after_display":"1,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":8287324,"accession":"0001209191-23-004005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-004005","line_url":"/filing/0001209191-23-004005#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":312.03,"price_display":"312.03","price_state":"stated","total_value":1248120.0,"total_display":"1,248,120.00","total_whole":"1,248,120","shares_owned_after":1875.0,"shares_owned_after_display":"1,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":6235502,"accession":"0000899243-22-015163","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-015163","line_url":"/filing/0000899243-22-015163","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":284.23332,"price_display":"284.23","price_state":"stated","total_value":568466.64,"total_display":"568,466.64","total_whole":"568,467","shares_owned_after":2485.0,"shares_owned_after_display":"2,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-20","scope":"insider","n_lines":4},{"id":6166782,"accession":"0000899243-22-014962","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-014962","line_url":"/filing/0000899243-22-014962","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":289.0583,"price_display":"289.06","price_state":"stated","total_value":578116.6,"total_display":"578,116.60","total_whole":"578,117","shares_owned_after":2927.0,"shares_owned_after_display":"2,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-14","filed_date":"2022-04-18","scope":"insider","n_lines":4},{"id":6166730,"accession":"0000899243-22-014804","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000899243-22-014804","line_url":"/filing/0000899243-22-014804","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":287.50475,"price_display":"287.50","price_state":"stated","total_value":575009.5,"total_display":"575,009.50","total_whole":"575,010","shares_owned_after":2429.0,"shares_owned_after_display":"2,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-13","filed_date":"2022-04-14","scope":"insider","n_lines":8},{"id":6166708,"accession":"0000899243-22-014804","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-014804","line_url":"/filing/0000899243-22-014804","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":281.02531,"price_display":"281.03","price_state":"stated","total_value":562050.62,"total_display":"562,050.62","total_whole":"562,051","shares_owned_after":2493.0,"shares_owned_after_display":"2,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-14","scope":"insider","n_lines":4},{"id":6318239,"accession":"0000899243-22-014551","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-22-014551","line_url":"/filing/0000899243-22-014551","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":280.29939,"price_display":"280.30","price_state":"stated","total_value":560598.78,"total_display":"560,598.78","total_whole":"560,599","shares_owned_after":1985.0,"shares_owned_after_display":"1,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-12","scope":"insider","n_lines":3},{"id":6318229,"accession":"0000899243-22-014551","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-014551","line_url":"/filing/0000899243-22-014551","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":278.57055,"price_display":"278.57","price_state":"stated","total_value":557141.1,"total_display":"557,141.10","total_whole":"557,141","shares_owned_after":2327.0,"shares_owned_after_display":"2,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-12","scope":"insider","n_lines":4},{"id":6235461,"accession":"0000899243-22-014367","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-22-014367","line_url":"/filing/0000899243-22-014367","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":274.860235,"price_display":"274.86","price_state":"stated","total_value":549720.47,"total_display":"549,720.47","total_whole":"549,720","shares_owned_after":1975.0,"shares_owned_after_display":"1,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2022-04-08","scope":"insider","n_lines":5},{"id":6235440,"accession":"0000899243-22-014367","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-014367","line_url":"/filing/0000899243-22-014367#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001334365","owner_name":"Lee Yuchun","owner_display_name":"Lee Yuchun","owner_url":"/insider/0001334365","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":271.78,"price_display":"271.78","price_state":"stated","total_value":434848.0,"total_display":"434,848.00","total_whole":"434,848","shares_owned_after":1958.0,"shares_owned_after_display":"1,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-06","filed_date":"2022-04-08","scope":"insider"}],"collapsed":true,"next_cursor":"2022-04-06|6235440","ledger_fault":false,"count":{"value":591,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":591,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":591},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Director","n_filings":25,"first_seen":"2015-09-03","last_seen":"2023-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001138804","name":"UNICA CORP","url":"/issuer/0001138804","role":"Director, Officer (President, CEO & Chairman), Ten percent owner","n_filings":36,"first_seen":"2006-09-08","last_seen":"2010-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001334365","retrieved_at":"2026-08-26T12:39:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}